Summary. The 
INTRODUCTION
Relatively little work has been done on the intermediary metabolism of smooth muscle (Carsten, 1968) , though a recent report indicated (Beatty, Basinger & Bocek, 1969 (Rändle, Garland, Hales & Newsholme, 1963; Jenkins, 1967; Williamson, Browning, Scholz, Kreisberg & Fritz, 1968) . This hypothesis, commonly called the glucose-fatty acid cycle theory, implies that increased availability of FFA and ketone bodies for oxidation is responsible for the decrease in glucose utilization by muscle (diaphragm and cardiac) and the increase in hepatic gluconeogenesis. However, conflicting experimental results in vivo were obtained in both dogs and humans when FFA levels were increased by oral or intravenous administration of fat (Ruderman, Toews & Shafrir, 1969 
Analyses
Glucose, lactate, and glycogen were determined as previously described (Beatty, Peterson, Basinger & Bocek, 1966 (Beatty et al., 1966) . For determination of the 14C activity in the lipid fraction, a 0-025-ml aliquot of the CHCl3:CH3OH extract of muscle washed to constant activity was counted in a liquid scintillation counter.
Hydroxyproline was estimated according to the method of Woessner (1961) , except that the HCl-digest of the muscle was passed through a Dowex-50 column (Moore & Stein, 1951) to separate hydroxyproline from the rest of the amino acids before colorimetrie analysis. The presence in plasma of a nonhydroxyproline chromophore, which interferes with the existing assays for hydroxyproline, has been reported (LeRoy, Kaplan, Udenfriend & Sjoerdsma, 1964) . However, after passage through the Dowex-50 column, no interfering chromophore was present in the hydroxyproline fraction. Bentley & Hanson (1969) have demonstrated the presence of hydroxyproline in elastin, but the amount is small compared to that in collagen (1/10); the amount of elastin compared to the amount of collagen in myometrium is also small . Therefore, we assumed that all of the hydroxyproline is in the collagen and that hydroxyproline represents 13-4% of collagenous protein (Newman & Logan, 1950) Effect of octanoate on 02 consumption and total C02 production One mM-octanoate had no effect on the 0O2 when compared to the control series; however, 4 mM decreased the oxygen consumption about 10% (Table 1) . Total C02 productions were not measured in the first series of experiments (Table 1) , but in the second series, when the octanoate level in the medium was increased from 0-4 to 4-0 mM ( (Williamson et al., 1968; Ruderman et al., 1969) . In view of the lack of effect of FFA on glucose uptake, it seemed necessary to prove that octanoate was being metabolized by this myometrial preparation. As can be seen in Table 2 , octanoate is well utilized by the myometrium. Increasing the octanoate Table 2 metabolism of [l-14c] (Shipp, Opie & Challoner, 1961; Rändle, Newsholme & Garland, 1964; Vahouny, Liljenquist, Wilson, Lioa & Rodis, 1968) . However, Cassens et al. (1969) were unable to show any effect of octanoate on glucose uptake by voluntary skeletal 314 Clarissa H. Beatty and Rose Mary Bocek muscle from the rhesus monkey. Hashimoto & Dayton (1968) were also unable to show an effect of octanoate or palmitate on glucose uptake by rat aorta. Using an isolated rat diaphragm preparation, Schonfeld & Kipnis (1968) reported that the FFA (palmitic and oleic) had no effect on glucose uptake over a wide range of concentrations. Since the inhibiting effect of FFA on enzyme activity is modified by the intracellular protein level (Shafrir, Lauris & Cahill, 1968) , one might postulate that cardiac muscle has a different protein concen¬ tration at the location of the key glycolytic enzymes than does smooth or voluntary skeletal muscle. Although Ruderman et al. (1969) concluded that FFA do influence glucose metabolism in the rat, Exton, Corbin & Park (1969) (Shipp etal., 1961; Shipp, 1964) and in rat aorta (Hashimoto & Dayton, 1968) .
The fact that octanoate had no effect on myometrial 02 consumption at a 0-4 mM concentration and only slightly decreased 02 consumption of 4 mM concentration is not in agreement with other published results in which octan¬ oate and other FFA stimulated the 02 consumption of perfused rat heart and voluntary striated muscle (Challoner & Steinberg, 1966; Cassens etal., 1969) . In view of the increase in 02 consumption in these tissues, several workers (Challoner & Steinberg, 1966; Ruderman et al., 1969) (1969) demonstrated that muscle fibre groups incubated in medium containing octa¬ noate had lower glycogen levels than control groups at the end of the experi¬ mental period; Exton et al. (1969) reported data suggesting that octanoate caused marked glycogenolysis in perfused rat liver. Net glycogen synthesis in perfused rat heart was either unchanged or increased (Rändle et al., 1964 (Mahler & Szabo, 1967; Hashimoto & Dayton, 1968) . The use of octanoate has been questioned because it is not a constituent of the mammalian FFA pool. However, Rändle et al. ( 1964) reported that the effects of octanoate and palmitate on the carbohydrate metabolism of perfused rat heart were similar; both octanoate and palmitate decreased the incorporation of 14C from leucine into the protein of isolated rat diaphragm (Buse & Buse, 1967) and perfused rat heart (Willingham, Biggars & Buse, 1969) . Both octanoate and oleate stimulated ketogenesis but not gluconeogenesis in perfused livers from rats (Exton & Park, 1967) . Marked species differences are apparent in the responses of a number of enzymes to diet and hormones (Scrutton & Utter, 1968) . There appear to be marked species differences in vivo in the response to an increase in plasma FFA. In rats, intraperitoneal octanoate raised the blood glucose level (Fried¬ man, Goodman & Weinhouse, 1967) . In dogs, intravenous octanoate (Sanbar, Evans, Boniface & Hetenyi, 1967) or oleate (Greenough, Crespin & Steinberg, 1967) or infusion of cottonseed oil followed by heparin to induce intravascular lipolysis (Seyffert & Madison, 1967) resulted in hypoglycaemia. In man, both an increase and a decrease in tolerance to intravenous glucose have been reported after plasma FFA levels were artificially raised (Ruderman et al., 1969) . How¬ ever, it is difficult to assess whether these results are due to changes in peri¬ pheral glucose utilization, to changes in hepatic glucogenesis, or to an increase in plasma insulin concentrations. An investigation of the individual tissues and organs that might be involved in the glucose-fatty acid cycle would appear to be essential. In view of these species differences, tissue from an animal as closely related to man as the rhesus monkey is an experimental tool of particular importance.
